Morphine-induced ocular hypotension is modulated by nitric oxide and carbon monoxide: Role of 3 receptors

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 1, 2010, Pages 31-35

  Stagni, Edoardo ^a   Bucolo, Claudio ^a   Motterlini, Roberto ^b   Drago, Filippo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; GLUTATHIONE; HEME OXYGENASE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR 3; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; OPIATE RECEPTOR; PROTOPORPHYRIN ZINC; RUTHENIUM DERIVATIVE; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; INDUCED HYPOTENSION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; NONHUMAN; PROTEIN FUNCTION; RABBIT; TONOMETRY;

ANIMALS; CARBON MONOXIDE; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); INTRAOCULAR PRESSURE; MORPHINE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OCULAR HYPOTENSION; PROTEIN ISOFORMS; PROTOPORPHYRINS; RABBITS; RECEPTORS, OPIOID, MU;

EID: 77649279559     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0081     Document Type: Article

References (32)

1. Stefano, G.B., Digenis, A., Spector, S., et al. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl. Acad. Sci. USA. 90:11099-11103, 1993.
2. Makman, M.H., Bilfi nger, T.V., and Stefano, G.B. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154:1323-1330, 1995.
3. Stefano, G.B., Hartman, A., Bilfi nger, T.V., et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270:30290-30293, 1995.
4. Cadet, P., Mantione, K.J., and Stefano, G.B. Molecular identifi cation and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J. Immunol. 170:5118-5123, 2003.
5. Cadet, P., Mantione, K.J., Bilfi nger, T.V., et al. Differential expression of the human mu opiate receptor from different primary vascular endothelial cells. Med. Sci. Monit. 10:BR351-BR355, 2004.
6. Prevot, V., Rialas, C.M., Croix, D., et al. Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res. 790:236-244, 1998.
7. Bonfi glio, V., Bucolo, C., Camillieri, G., et al. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits. Eur. J. Pharmacol. 534:227-232, 2006.
8. Dortch-Carnes, J., and Russell, K.R. Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide. Pharmacology. 77:17-24, 2006.
9. Liang, D.Y., and Clark, J.D. Modulation of the NO/CO-cGMP signaling cascade during chronic morphine exposure in mice. Neurosci. Lett. 365:73-77, 2004.
10. Maines, M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517-554, 1997.
11. Giuffrida, S., Bucolo, C., and Drago, F. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J. Ocul. Pharmacol. Ther. 19:527-534, 2003.
12. Cao, L., Blute, T.A., and Eldred, W.D. Localization of heme oxygenase-2 and modulation of cGMP levels by carbon monoxide and/or nitric oxide in the retina. Vis. Neurosci. 17:319-329, 2000.
13. Cao, L., and Eldred, W.D. Inhibitors of nitric oxide synthase block carbon monoxide-induced increases in cGMP in retina. Brain Res. 988:78-83, 2003.
14. Chiou, G.C.Y., Liu, S.X.L., Li, B.H.P., et al. Ocular hypotensive effects of l-arginine and its derivatives and their actions on ocular blood fl ow. J. Ocular. Pharmacol. Ther. 11:1-10, 1995.
15. Kotikoski, H., Alajuuma, P., Moilanen, E., et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J. Ocul. Pharmacol. Ther. 18:11-23, 2002.
16. Krupin, T., Weiss, A., Becker, B., et al. Increased intraocular pressure following topical azide or nitroprusside. Invest. Ophthalmol. Vis. Sci. 16:1002-1007, 1977.
17. Privitera, M.G., Potenza, M., Bucolo, C., et al. Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits. J. Ocul. Pharmacol. Ther. 23:232-239, 2007.
18. Stagni, E., Privitera, M.G., Bucolo, C., et al. A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits. Br. J. Ophthalmol. 93:254-257, 2009.
19. Clark, J.E., Naughton, P., Shurey, S., et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ. Res. 93:e2-e8, 2003.
20. Stefano, G.B., Zhu, W., Cadet, P., et al. Morphine enhances nitric oxide release in the mammalian gastrointestinal tract via the micro(3) opiate receptor subtype: a hormonal role for endogenous morphine. J. Physiol. Pharmacol. 55:279-288, 2004.
21. Nathanson, J.A., and McKee, M. Identifi cation of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest. Ophthalmol. Vis. Sci. 36:1765-1773, 1995.
22. Haefliger, I.O., Dettmann, E., Liu, R., et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv. Ophthalmol. 43(Suppl 1):S51-S58, 1999.
23. Tsai, D.C., Hsu, W.M., Chou, C.K., et al. Signifi cant variation of the elevated nitric oxide levels in aqueous humor from patients with different types of glaucoma. Ophthalmologica. 216:346-350, 2002.
24. Shahidullah, M., Yap, M., and To, C.H. Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye. Br. J. Pharmacol. 145:84-92, 2005.
25. Carreiro, S., Anderson, S., Gukasyan, H.J., et al. Correlation of in vitro and in vivo kinetics of nitric oxide donors in ocular tissues. J. Ocular Pharmacol. Ther. 25:105-112, 2009.
26. Fleischhauer, J.C., Bény, J.L., Flammer, J., et al. NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium. Invest. Ophthalmol. Vis. Sci. 41:1759-1763, 2000.
27. Makman, M.H., Dobrenis, K., Downie, S., et al. Presence of opiate alkaloid-selective mu3 receptors in cultured astrocytes and in brain and retina. Adv. Exp. Med. Biol. 402:23-28, 1996.
28. Drago, F., Facchinetti, F., Petraglia, F., et al. Ocular opioids: distribution and function. In: Muller, E.E., Genazzani, A.R., eds. Central and Peripheral Endorphins: Basic and Clinical Aspects. New York: Raven Press; 1984a; p. 151-155.
29. Drago, F., Gorgone, G., Dal Bello, A., et al. Endorphins in the eye: evidence for a possible local action. In: Fraioli, F., Isidori, A., eds. Opioid Peptides in Periphery. New York: Raven Press; 1984b; p. 119-126.
30. Drago, F., Panissidi, G., Bellomio, F., et al. Effects of opiates and opioids on intraocular pressure of rabbits and humans. Clin. Exp. Pharmacol. Physiol. 12:107-113, 1985.
31. Murad, F. Nitric oxide and cyclic guanosine monophosphate signaling in the eye. Can. J. Ophthalmol. 43:291-294, 2008.
32. Patil, K., Bellner, L., Cullaro, G., et al. Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest. Ophthalmol. Vis. Sci. 49:3379-3386, 2008.